BioCryst Pharmaceuticals Inc (NAS:BCRX)
$ 8.11 -0.04 (-0.49%) Market Cap: 1.68 Bil Enterprise Value: 2.24 Bil PE Ratio: 0 PB Ratio: 0 GF Score: 74/100

Q2 2019 BioCryst Pharmaceuticals Inc Earnings Call Transcript

Aug 06, 2019 / 12:30PM GMT
Release Date Price: $2.97 (+4.58%)
Operator

Good day, ladies and gentlemen, and welcome to the BioCryst's Second Quarter 2019 Earnings Call. (Operator Instructions) As a reminder, today's conference is being recorded. I would now like to turn the call over to John Bluth at BioCryst. Sir, you may begin.

John D. Bluth
BioCryst Pharmaceuticals, Inc. - SVP of IR & Corporate Communications

Thank you, Sydney. Good morning and welcome to BioCryst Second Quarter 2019 Corporate Update and Financial Results Conference Call. Today's press release is available on our website. Participating with me today are CEO, Jon Stonehouse; Chief Medical Officer, Dr. Bill Sheridan; CFO, Tom Staab; and Chief Business Officer, Megan Sniecinski. Following our remarks, we will answer your questions.

Before we begin, please note that today's conference call will contain forward-looking statements, including those statements regarding future results, unaudited and forward-looking financial information as well as the company's future performance and/or achievements. These statements are subject to known and unknown risks

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot